A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate, in Participants With Advanced Solid Tumors

NCT06625593 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

168

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: BG-C137
DRUG: Anticancer Agents

Sponsor

BeOne Medicines